Literature DB >> 17045081

Epidemiologic aspects of renal cell carcinoma.

Joseph K McLaughlin1, Loren Lipworth, Robert E Tarone.   

Abstract

Renal cell cancer accounts for 2% of all new cancer cases worldwide. Incidence rates have been rising steadily around the world. In the United States, the rates have been rapidly increasing among black Americans, whose incidence rate has now surpassed that of white Americans. Cigarette smoking and obesity are the most consistently established causal risk factors, accounting for more than 20% and 30% of renal cell cancers, respectively. Hypertension, rather than antihypertensive drugs, appears to influence renal cell cancer development, although the mechanism is unknown. Analgesics have not been convincingly linked with renal cell cancer risk. In general, there appears to be a protective effect of fruit and vegetable consumption, although no particular component of diet has been clearly implicated. There are sporadic and inconsistent reports of occupations or occupational exposures being associated with this cancer. Epidemiologic studies are needed to identify reasons for the increasing incidence of renal cell cancer, with particular focus on why the incidence rate for black Americans has risen to significantly surpass that of white Americans.

Entities:  

Mesh:

Year:  2006        PMID: 17045081     DOI: 10.1053/j.seminoncol.2006.06.010

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  42 in total

Review 1.  Aspirin and urologic cancer risk: an update.

Authors:  Cristina Bosetti; Valentina Rosato; Silvano Gallus; Carlo La Vecchia
Journal:  Nat Rev Urol       Date:  2012-01-24       Impact factor: 14.432

2.  Dietary Inflammatory Index and Renal Cell Carcinoma Risk in an Italian Case-Control Study.

Authors:  Nitin Shivappa; James R Hébert; Valentina Rosato; Marta Rossi; Maurizio Montella; Diego Serraino; Carlo La Vecchia
Journal:  Nutr Cancer       Date:  2017-07-18       Impact factor: 2.900

3.  Orthotopic xenografts of RCC retain histological, immunophenotypic and genetic features of tumours in patients.

Authors:  Chiara Grisanzio; Apryle Seeley; Michelle Chang; Michael Collins; Arianna Di Napoli; Su-Chun Cheng; Andrew Percy; Rameen Beroukhim; Sabina Signoretti
Journal:  J Pathol       Date:  2011-06-27       Impact factor: 7.996

4.  Native nephrectomy in transplant patients with autosomal dominant polycystic kidney disease.

Authors:  P Patel; C Horsfield; F Compton; J Taylor; G Koffman; J Olsburgh
Journal:  Ann R Coll Surg Engl       Date:  2011-07       Impact factor: 1.891

5.  Overexpression of placenta specific 8 is associated with malignant progression and poor prognosis of clear cell renal cell carcinoma.

Authors:  Liping Shi; Long Xiao; Baoli Heng; Shijie Mo; Weijun Chen; Zexuan Su
Journal:  Int Urol Nephrol       Date:  2017-03-27       Impact factor: 2.370

6.  Methylation of STK11 promoter is a risk factor for tumor stage and survival in clear cell renal cell carcinoma.

Authors:  Fufu Zheng; Xiaoxu Yuan; Enjing Chen; Yunlin Ye; Xiaofei Li; Yuping Dai
Journal:  Oncol Lett       Date:  2017-07-07       Impact factor: 2.967

7.  Management of side effects associated with sunitinib therapy for patients with renal cell carcinoma.

Authors:  Anita Schwandt; Laura S Wood; Brian Rini; Robert Dreicer
Journal:  Onco Targets Ther       Date:  2009-02-18       Impact factor: 4.147

8.  Review of US Comparative Economic Evidence for Treatment of Metastatic Renal Cell Carcinoma after Failure of First-Line VEGF Inhibitor Therapy.

Authors:  Michael K Wong; Xufang Wang; Maruit J Chulikavit; Zhimei Liu
Journal:  Am Health Drug Benefits       Date:  2013-07

9.  Efficacy and safety of sorafenib in patients with advanced renal cell carcinoma with and without prior cytokine therapy, a subanalysis of TARGET.

Authors:  S Negrier; E Jäger; C Porta; D McDermott; M Moore; J Bellmunt; S Anderson; F Cihon; J Lewis; B Escudier; R Bukowski
Journal:  Med Oncol       Date:  2009-09-12       Impact factor: 3.064

10.  [Transcriptome analyses in renal cell carcinoma. Combination of laser microdissection and microarrays].

Authors:  A Buchner; M Castro; A Hennig; T Popp; G Assmann; A Hofstetter; C Stief; W Zimmermann
Journal:  Urologe A       Date:  2007-09       Impact factor: 0.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.